Kathryn de Santis

TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA.

Project Management Institute, Inc. provides project management services. Its advance careers improve organizational success and further mature the profession of project management through globally recognized standards, certifications, resources, tools, academic research, publications, professional development courses and networking opportunities. The company was founded by James Snyder, Eric Jenett, Gordon Davis, E. A. Engman and Susan C. Gallagher in 1969 and is headquartered in Philadelphia, PA.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Medtronic MiniMed, Inc. manufactures insulin pumps and glucose monitoring systems. Its products include minimed 530g system, smartguard, enlite sensor, minimed revel and infusion sets. The company was founded by Alfred E. Mann in 1979 and is headquartered in Northridge, CA.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD.

JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China.

Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA.